Kailash C. Agarwal

1.5k total citations · 1 hit paper
41 papers, 1.2k citations indexed

About

Kailash C. Agarwal is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Kailash C. Agarwal has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Physiology and 8 papers in Pharmacology. Recurrent topics in Kailash C. Agarwal's work include Adenosine and Purinergic Signaling (13 papers), Biochemical and Molecular Research (9 papers) and Platelet Disorders and Treatments (5 papers). Kailash C. Agarwal is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Biochemical and Molecular Research (9 papers) and Platelet Disorders and Treatments (5 papers). Kailash C. Agarwal collaborates with scholars based in United States and India. Kailash C. Agarwal's co-authors include Robert E. Parks, Doloretta D. Dawicki, Ram P. Agarwal, Johanna D. Stoeckler, George N. Tzanakakis, Michael P. Vezeridis, Karl Schmid, Eric Scholar, Gerald W. Crabtree and Alfred W. Senft and has published in prestigious journals such as Biochemistry, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Kailash C. Agarwal

40 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic actions of garlic constituents

1996 536 citations Kailash C. Agarwal Medicinal Research Reviews profile →

Peers

Countries citing papers authored by Kailash C. Agarwal

Since Specialization

Citations

This map shows the geographic impact of Kailash C. Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailash C. Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailash C. Agarwal more than expected).

Fields of papers citing papers by Kailash C. Agarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kailash C. Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailash C. Agarwal. The network helps show where Kailash C. Agarwal may publish in the future.

Co-authorship network of co-authors of Kailash C. Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Kailash C. Agarwal. A scholar is included among the top collaborators of Kailash C. Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kailash C. Agarwal. Kailash C. Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure 2017 ·Turkish Thoracic Journal ·(unknown), V. K. Joshi, Naveen Dutt, Surjit Singh, Kailash C. Agarwal, (unknown)	23
2	The Effect of 6 Week Pulmonary Rehabilitation in COPD - A Randomized Control Study 2013 ·CHEST Journal ·(unknown), V. K. Joshi, Kailash C. Agarwal, (unknown), (unknown), Shital Patil	3
3	Left heart dysfunction in COPD- Ignored combination 2013 ·European Respiratory Journal ·Deepak Singh, Kailash C. Agarwal, V. K. Joshi, (unknown), Shital Patil	1
4	Infection of Albugo candida (Pers. ex Lev.) Kunze in mustard seeds. 1997 ·(unknown), Kailash C. Agarwal, (unknown)	1
5	Therapeutic actions of garlic constituents breakdown → 1996 ·Medicinal Research Reviews ·Kailash C. Agarwal	536
6	Platelet-activating factor (PAF)-induced platelet aggregation modulation by plasma adenosine and methylxanthines 1994 ·Biochemical Pharmacology ·Kailash C. Agarwal, (unknown), Sharon Rounds, Robert E. Parks, Huzoor‐Akbar	13
7	Modulation of Vasopressin Actions on Human Platelets by Plasma Adenosine and Theophylline 1993 ·Journal of Cardiovascular Pharmacology ·Kailash C. Agarwal	19
8	Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233 1993 ·Cancer ·George N. Tzanakakis, Kailash C. Agarwal, Michael P. Vezeridis	33
9	Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy 1992 ·The American Journal of Cardiology ·Marilyn M. Barbour, Carol Ewing Garber, Kailash C. Agarwal, Rahul Malhotra, Gary V. Heller	3
10	Effects of antiplatelet agents alone or in combinations on platelet aggregation and on liver metastases from a human pancreatic adenocarcinoma in the nude mouse 1991 ·Journal of Surgical Oncology ·George N. Tzanakakis, Kailash C. Agarwal, (unknown), Michael P. Vezeridis	14
11	Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole 1990 ·Cancer ·George N. Tzanakakis, Kailash C. Agarwal, Michael P. Vezeridis	21
12	Adenosine metabolism in human whole blood 1988 ·Biochemical Pharmacology ·Doloretta D. Dawicki, Kailash C. Agarwal, Robert E. Parks	34
13	Effects of antiplatelet drugs on pulmonary responses to thrombin in anesthetized rabbits 1987 ·Thrombosis Research ·(unknown), Stephen J. Warburton, Faysal M. Hasan, Carl Teplitz, (unknown), (unknown), Kailash C. Agarwal	2
14	Role of plasma adenosine in the antiplatelet action of hl 725, a potent inhibitor of camp phosphodiesterase: Species differences. 1987 ·Thrombosis Research ·Kailash C. Agarwal, (unknown), Robert E. Parks	10
15	Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dillazep and the camp phosphodiesterase inhibitor, RA 233 1986 ·Thrombosis Research ·Doloretta D. Dawicki, Kailash C. Agarwal, Robert E. Parks	26
16	Adenosine analogs and human platelets—II 1979 ·Biochemical Pharmacology ·Kailash C. Agarwal, Robert E. Parks, Leroy B. Townsend	8
17	Reassessment of the interactions of guanylate kinase and 6-thioguanosine 5′-phosphate 1977 ·Biochemical Pharmacology ·Richard L. Miller, (unknown), Thomas Spector, Kailash C. Agarwal, Ralph P. Miech, Robert E. Parks	11
18	Adenosine analogs and human platelets 1975 ·Biochemical Pharmacology ·Kailash C. Agarwal, Robert E. Parks	32
19	Inhibition of rat hepatic guanylate kinase by 6-thioguanosine-5′-phosphate and 6-selenoguanosine-5′-phosphate 1975 ·Biochemical Pharmacology ·Kailash C. Agarwal, Robert E. Parks	4
20	Adenosine Triphosphate—Guanosine 5'-Phosphate Phosphotransferase 1972 ·Molecular Pharmacology ·Kailash C. Agarwal, Robert E. Parks	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact